Fig. 4

Metabolite set enrichment analysis: The top 25 metabolic pathways distinguishing the high-residential radon exposure group from the low-residential radon exposure group (a) and diseases associated with metabolites in the high-residential radon exposure group compared with the low-residential radon exposure group (b).